

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.38010042 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.30845932 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.30845932 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.30845932 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.30845932 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.30845932 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.30845932 |
| 8 | microglial cell activation (GO:0001774) | 4.90906398 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.90427821 |
| 10 | signal peptide processing (GO:0006465) | 4.78406347 |
| 11 | glycolipid catabolic process (GO:0019377) | 4.75073811 |
| 12 | glycosphingolipid catabolic process (GO:0046479) | 4.69221860 |
| 13 | ceramide catabolic process (GO:0046514) | 4.54097071 |
| 14 | neutrophil mediated immunity (GO:0002446) | 4.44412606 |
| 15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.38369200 |
| 16 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.29046252 |
| 17 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.29046252 |
| 18 | phagosome maturation (GO:0090382) | 4.26454036 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.23207044 |
| 20 | glycoside metabolic process (GO:0016137) | 4.22946604 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.12131208 |
| 22 | respiratory burst (GO:0045730) | 4.10135558 |
| 23 | adaptation of signaling pathway (GO:0023058) | 4.09695686 |
| 24 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.07560568 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.01936707 |
| 26 | response to host immune response (GO:0052572) | 4.01852212 |
| 27 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.01852212 |
| 28 | tryptophan metabolic process (GO:0006568) | 3.98509511 |
| 29 | transferrin transport (GO:0033572) | 3.95803606 |
| 30 | negative regulation of interleukin-17 production (GO:0032700) | 3.77590743 |
| 31 | nucleoside diphosphate catabolic process (GO:0009134) | 3.77007460 |
| 32 | indolalkylamine metabolic process (GO:0006586) | 3.71553037 |
| 33 | indole-containing compound catabolic process (GO:0042436) | 3.71448041 |
| 34 | indolalkylamine catabolic process (GO:0046218) | 3.71448041 |
| 35 | tryptophan catabolic process (GO:0006569) | 3.71448041 |
| 36 | platelet dense granule organization (GO:0060155) | 3.67774652 |
| 37 | negative regulation of mast cell activation (GO:0033004) | 3.63842329 |
| 38 | sphingolipid catabolic process (GO:0030149) | 3.62168805 |
| 39 | trivalent inorganic cation transport (GO:0072512) | 3.61276263 |
| 40 | ferric iron transport (GO:0015682) | 3.61276263 |
| 41 | macrophage activation (GO:0042116) | 3.55386254 |
| 42 | mannosylation (GO:0097502) | 3.54808679 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.53202942 |
| 44 | Golgi transport vesicle coating (GO:0048200) | 3.53202942 |
| 45 | membrane lipid catabolic process (GO:0046466) | 3.46904572 |
| 46 | piRNA metabolic process (GO:0034587) | 3.45760234 |
| 47 | response to host (GO:0075136) | 3.44345837 |
| 48 | response to host defenses (GO:0052200) | 3.44345837 |
| 49 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.44345837 |
| 50 | protein-cofactor linkage (GO:0018065) | 3.41727032 |
| 51 | response to peptidoglycan (GO:0032494) | 3.40099087 |
| 52 | keratan sulfate catabolic process (GO:0042340) | 3.36152573 |
| 53 | cellular ketone body metabolic process (GO:0046950) | 3.34099500 |
| 54 | pH reduction (GO:0045851) | 3.33984935 |
| 55 | positive regulation of antigen processing and presentation (GO:0002579) | 3.33223759 |
| 56 | response to pheromone (GO:0019236) | 3.31633079 |
| 57 | amino sugar catabolic process (GO:0046348) | 3.30909803 |
| 58 | myeloid leukocyte mediated immunity (GO:0002444) | 3.29363760 |
| 59 | acrosome reaction (GO:0007340) | 3.28888318 |
| 60 | adenosine metabolic process (GO:0046085) | 3.28542178 |
| 61 | intracellular pH reduction (GO:0051452) | 3.28344993 |
| 62 | establishment of protein localization to Golgi (GO:0072600) | 3.21269121 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20078063 |
| 64 | amine catabolic process (GO:0009310) | 3.19577845 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 3.19577845 |
| 66 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.19487898 |
| 67 | alanine transport (GO:0032328) | 3.18965434 |
| 68 | cell wall macromolecule metabolic process (GO:0044036) | 3.15713534 |
| 69 | cell wall macromolecule catabolic process (GO:0016998) | 3.15713534 |
| 70 | myeloid cell activation involved in immune response (GO:0002275) | 3.15663972 |
| 71 | regulation of mast cell activation (GO:0033003) | 3.14815512 |
| 72 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.13611222 |
| 73 | regulation of hexokinase activity (GO:1903299) | 3.11326583 |
| 74 | regulation of glucokinase activity (GO:0033131) | 3.11326583 |
| 75 | respiratory chain complex IV assembly (GO:0008535) | 3.11217247 |
| 76 | mannose metabolic process (GO:0006013) | 3.10788675 |
| 77 | positive regulation of action potential (GO:0045760) | 3.09503672 |
| 78 | DNA deamination (GO:0045006) | 3.09024655 |
| 79 | protein retention in ER lumen (GO:0006621) | 3.08963539 |
| 80 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.07871322 |
| 81 | behavioral response to nicotine (GO:0035095) | 3.05530042 |
| 82 | superoxide anion generation (GO:0042554) | 3.04421652 |
| 83 | regulation of mast cell degranulation (GO:0043304) | 3.04233881 |
| 84 | protein targeting to Golgi (GO:0000042) | 3.03695267 |
| 85 | positive regulation of mast cell activation (GO:0033005) | 3.03022745 |
| 86 | sperm motility (GO:0030317) | 3.02922397 |
| 87 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00168718 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.98360794 |
| 89 | regulation of memory T cell differentiation (GO:0043380) | 2.96545485 |
| 90 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.96298228 |
| 91 | cytidine metabolic process (GO:0046087) | 2.94767742 |
| 92 | cytidine catabolic process (GO:0006216) | 2.94767742 |
| 93 | cytidine deamination (GO:0009972) | 2.94767742 |
| 94 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.93784157 |
| 95 | pinocytosis (GO:0006907) | 2.92019925 |
| 96 | nucleotide transmembrane transport (GO:1901679) | 2.89817186 |
| 97 | ketone body metabolic process (GO:1902224) | 2.89687830 |
| 98 | regulation of autophagic vacuole assembly (GO:2000785) | 2.89586339 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 2.86892693 |
| 100 | immunoglobulin mediated immune response (GO:0016064) | 2.86805939 |
| 101 | iron ion transport (GO:0006826) | 2.85844255 |
| 102 | protein K11-linked deubiquitination (GO:0035871) | 2.85629490 |
| 103 | glycosylceramide metabolic process (GO:0006677) | 2.85030649 |
| 104 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.84742182 |
| 105 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.82555126 |
| 106 | polyketide metabolic process (GO:0030638) | 2.82312468 |
| 107 | doxorubicin metabolic process (GO:0044598) | 2.82312468 |
| 108 | daunorubicin metabolic process (GO:0044597) | 2.82312468 |
| 109 | plasma membrane fusion (GO:0045026) | 2.82046875 |
| 110 | endosome to pigment granule transport (GO:0043485) | 2.80940113 |
| 111 | endosome to melanosome transport (GO:0035646) | 2.80940113 |
| 112 | glycerophospholipid catabolic process (GO:0046475) | 2.80853785 |
| 113 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.79995968 |
| 114 | inositol phosphate catabolic process (GO:0071545) | 2.79443703 |
| 115 | regulation of cilium movement (GO:0003352) | 2.78540155 |
| 116 | lysosome organization (GO:0007040) | 2.78063186 |
| 117 | lytic vacuole organization (GO:0080171) | 2.78063186 |
| 118 | DNA methylation involved in gamete generation (GO:0043046) | 2.77316343 |
| 119 | axoneme assembly (GO:0035082) | 2.77170382 |
| 120 | neutrophil activation (GO:0042119) | 2.76665396 |
| 121 | fucose metabolic process (GO:0006004) | 2.75720616 |
| 122 | cytochrome complex assembly (GO:0017004) | 2.75501677 |
| 123 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.72025800 |
| 124 | positive regulation of mast cell degranulation (GO:0043306) | 2.72025800 |
| 125 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.68944550 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68441962 |
| 127 | regulation of interferon-alpha production (GO:0032647) | 2.68152714 |
| 128 | GDP-mannose metabolic process (GO:0019673) | 2.66802242 |
| 129 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.65450784 |
| 130 | glycosphingolipid metabolic process (GO:0006687) | 2.63587466 |
| 131 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.63163653 |
| 132 | multicellular organism reproduction (GO:0032504) | 2.62829166 |
| 133 | S-adenosylmethionine metabolic process (GO:0046500) | 2.61942974 |
| 134 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.60801084 |
| 135 | organic cation transport (GO:0015695) | 2.59822661 |
| 136 | granulocyte activation (GO:0036230) | 2.59655592 |
| 137 | regulation of action potential (GO:0098900) | 2.59379544 |
| 138 | response to thyroid hormone (GO:0097066) | 2.59206842 |
| 139 | oligosaccharide catabolic process (GO:0009313) | 2.58352179 |
| 140 | autophagic vacuole fusion (GO:0000046) | 2.57926412 |
| 141 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.57553376 |
| 142 | inositol phosphate dephosphorylation (GO:0046855) | 2.57553376 |
| 143 | axonemal dynein complex assembly (GO:0070286) | 2.56577076 |
| 144 | C-terminal protein lipidation (GO:0006501) | 2.56318134 |
| 145 | protein maturation by protein folding (GO:0022417) | 2.56170591 |
| 146 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55661671 |
| 147 | C-terminal protein amino acid modification (GO:0018410) | 2.54856347 |
| 148 | protein localization to Golgi apparatus (GO:0034067) | 2.54151367 |
| 149 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.53732608 |
| 150 | detection of molecule of bacterial origin (GO:0032490) | 2.53398726 |
| 151 | detection of light stimulus involved in visual perception (GO:0050908) | 2.53396051 |
| 152 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.53396051 |
| 153 | indole-containing compound metabolic process (GO:0042430) | 2.53259477 |
| 154 | positive regulation of receptor recycling (GO:0001921) | 2.52611157 |
| 155 | glucosamine-containing compound catabolic process (GO:1901072) | 2.52447759 |
| 156 | T-helper cell differentiation (GO:0042093) | 2.52114425 |
| 157 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.52114425 |
| 158 | nitric oxide biosynthetic process (GO:0006809) | 2.51749412 |
| 159 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.49916697 |
| 160 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.49150647 |
| 161 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.49150647 |
| 162 | positive regulation of regulated secretory pathway (GO:1903307) | 2.48672244 |
| 163 | eosinophil chemotaxis (GO:0048245) | 2.46033792 |
| 164 | actin nucleation (GO:0045010) | 2.44713877 |
| 165 | early endosome to late endosome transport (GO:0045022) | 2.43926185 |
| 166 | benzene-containing compound metabolic process (GO:0042537) | 2.42663813 |
| 167 | regulation of germinal center formation (GO:0002634) | 2.41634272 |
| 168 | aromatic amino acid family catabolic process (GO:0009074) | 2.41249327 |
| 169 | sphingosine metabolic process (GO:0006670) | 2.41225071 |
| 170 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.40386847 |
| 171 | detection of calcium ion (GO:0005513) | 2.40215967 |
| 172 | regulation of cell killing (GO:0031341) | 2.39742117 |
| 173 | mitochondrial calcium ion transport (GO:0006851) | 2.38909217 |
| 174 | estrogen biosynthetic process (GO:0006703) | 2.38480998 |
| 175 | regulation of vacuole organization (GO:0044088) | 2.38352862 |
| 176 | NAD biosynthetic process (GO:0009435) | 2.36527241 |
| 177 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.36490101 |
| 178 | anterograde synaptic vesicle transport (GO:0048490) | 2.36446053 |
| 179 | basic amino acid transport (GO:0015802) | 2.35734569 |
| 180 | aromatic amino acid family metabolic process (GO:0009072) | 2.34992356 |
| 181 | fucose catabolic process (GO:0019317) | 2.33714521 |
| 182 | L-fucose metabolic process (GO:0042354) | 2.33714521 |
| 183 | L-fucose catabolic process (GO:0042355) | 2.33714521 |
| 184 | macroautophagy (GO:0016236) | 2.32987859 |
| 185 | interferon-gamma production (GO:0032609) | 2.32297444 |
| 186 | diol metabolic process (GO:0034311) | 2.31379246 |
| 187 | zinc ion homeostasis (GO:0055069) | 2.31365867 |
| 188 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.30911802 |
| 189 | polyol catabolic process (GO:0046174) | 2.29572051 |
| 190 | T cell differentiation involved in immune response (GO:0002292) | 2.29431927 |
| 191 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.29431927 |
| 192 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.29431927 |
| 193 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.27851929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.01006829 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.83434876 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.20316189 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00009832 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.60695948 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.33181437 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24319174 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.24043702 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.12156605 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.08152402 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71152516 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.54846146 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43551388 |
| 14 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.41024535 |
| 15 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39469362 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39138293 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27772411 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26541764 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23015638 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16705571 |
| 21 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.13921242 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07713988 |
| 23 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.05327861 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96953420 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96647993 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95366685 |
| 27 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.89362307 |
| 28 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.87465673 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79227918 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78078084 |
| 31 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.76177066 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.74949832 |
| 33 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.70538891 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69086297 |
| 35 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.67699948 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64525398 |
| 37 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61608599 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58647103 |
| 39 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.58286692 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.57813665 |
| 41 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56795297 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54735143 |
| 43 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54678944 |
| 44 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.54325319 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53043248 |
| 46 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45668323 |
| 47 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.43834263 |
| 48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.43609180 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42963412 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42276346 |
| 51 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42194871 |
| 52 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41894930 |
| 53 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41118368 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37852301 |
| 55 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.37298006 |
| 56 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.36689508 |
| 57 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.36689508 |
| 58 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.36046700 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35882314 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34350368 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.31732450 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.31732450 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31716474 |
| 64 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.30439709 |
| 65 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29383250 |
| 66 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29264042 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27700712 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27472008 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.26831939 |
| 70 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.26202143 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26070925 |
| 72 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25351659 |
| 73 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25351659 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25039119 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24924696 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24830569 |
| 77 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23303206 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23147697 |
| 79 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.22692440 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22072168 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20741193 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19926282 |
| 83 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19233596 |
| 84 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.18404235 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18258275 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.17967640 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17966346 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16723712 |
| 89 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16417921 |
| 90 | MYB_26560356_Chip-Seq_TH2_Human | 1.15858404 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.15796176 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14800087 |
| 93 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13628962 |
| 94 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12888338 |
| 95 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12210536 |
| 96 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.12014321 |
| 97 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11446710 |
| 98 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10952686 |
| 99 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10936015 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.10755699 |
| 101 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10184528 |
| 102 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08782336 |
| 103 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08400825 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07423675 |
| 105 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06660570 |
| 106 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06583095 |
| 107 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06493936 |
| 108 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06413758 |
| 109 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.05367996 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05324635 |
| 111 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05194493 |
| 112 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05104875 |
| 113 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03446030 |
| 114 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.03389596 |
| 115 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.02471183 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02242229 |
| 117 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.01884603 |
| 118 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01778877 |
| 119 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00973384 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00209797 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00084019 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00073984 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99813440 |
| 124 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98640893 |
| 125 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98450636 |
| 126 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.98360650 |
| 127 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97905614 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97594383 |
| 129 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.97411768 |
| 130 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96074517 |
| 131 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95264934 |
| 132 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95126721 |
| 133 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94146509 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94075977 |
| 135 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93954155 |
| 136 | EWS_26573619_Chip-Seq_HEK293_Human | 0.93814101 |
| 137 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92254754 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91600330 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89366819 |
| 140 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87997291 |
| 141 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.86524210 |
| 142 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.86051209 |
| 143 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85833340 |
| 144 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84011591 |
| 145 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.83541028 |
| 146 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83124052 |
| 147 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82920678 |
| 148 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82251483 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82201108 |
| 150 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.81751742 |
| 151 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.80294866 |
| 152 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80258590 |
| 153 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80016276 |
| 154 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.79625119 |
| 155 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78504131 |
| 156 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.78483707 |
| 157 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.77515840 |
| 158 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.77155312 |
| 159 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76878571 |
| 160 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.76786259 |
| 161 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.76702403 |
| 162 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76196321 |
| 163 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76151679 |
| 164 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75852759 |
| 165 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.74937660 |
| 166 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72461443 |
| 167 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.71882562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 6.66592842 |
| 2 | MP0003172_abnormal_lysosome_physiology | 5.19053835 |
| 3 | MP0003183_abnormal_peptide_metabolism | 4.20801533 |
| 4 | MP0005410_abnormal_fertilization | 3.18948487 |
| 5 | MP0010386_abnormal_urinary_bladder | 3.01103151 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.65532833 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.43900136 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.43832193 |
| 9 | MP0002419_abnormal_innate_immunity | 2.34688853 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.32914257 |
| 11 | MP0001986_abnormal_taste_sensitivity | 2.30385411 |
| 12 | MP0006072_abnormal_retinal_apoptosis | 2.27168728 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.23646930 |
| 14 | MP0003878_abnormal_ear_physiology | 2.23646930 |
| 15 | MP0000015_abnormal_ear_pigmentation | 2.22798378 |
| 16 | MP0002102_abnormal_ear_morphology | 2.15845305 |
| 17 | MP0005670_abnormal_white_adipose | 2.15413448 |
| 18 | MP0006082_CNS_inflammation | 2.10576731 |
| 19 | MP0003011_delayed_dark_adaptation | 1.97152500 |
| 20 | MP0005253_abnormal_eye_physiology | 1.95226207 |
| 21 | MP0005167_abnormal_blood-brain_barrier | 1.93313630 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.88680919 |
| 23 | MP0003646_muscle_fatigue | 1.88529224 |
| 24 | MP0003436_decreased_susceptibility_to | 1.86264635 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.86246933 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.83118708 |
| 27 | MP0008260_abnormal_autophagy | 1.82614251 |
| 28 | MP0001661_extended_life_span | 1.76310754 |
| 29 | MP0003195_calcinosis | 1.75710804 |
| 30 | MP0002638_abnormal_pupillary_reflex | 1.72801430 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.72498415 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.68019479 |
| 33 | MP0002009_preneoplasia | 1.64891847 |
| 34 | MP0002693_abnormal_pancreas_physiology | 1.61723986 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.60264265 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.55399488 |
| 37 | MP0008875_abnormal_xenobiotic_pharmacok | 1.54329316 |
| 38 | MP0000343_altered_response_to | 1.53979347 |
| 39 | MP0004510_myositis | 1.51571659 |
| 40 | MP0000604_amyloidosis | 1.50329625 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.49021837 |
| 42 | MP0003690_abnormal_glial_cell | 1.47183983 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.47147996 |
| 44 | MP0005379_endocrine/exocrine_gland_phen | 1.46907128 |
| 45 | MP0009785_altered_susceptibility_to | 1.45850710 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.45440342 |
| 47 | MP0005332_abnormal_amino_acid | 1.44566575 |
| 48 | MP0009764_decreased_sensitivity_to | 1.43615417 |
| 49 | MP0003724_increased_susceptibility_to | 1.38373317 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.36951043 |
| 51 | MP0009840_abnormal_foam_cell | 1.34895478 |
| 52 | MP0005025_abnormal_response_to | 1.33928608 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.33389882 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.32197697 |
| 55 | MP0000427_abnormal_hair_cycle | 1.32092579 |
| 56 | MP0004147_increased_porphyrin_level | 1.31099060 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.30873451 |
| 58 | MP0000681_abnormal_thyroid_gland | 1.30660926 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.29766473 |
| 60 | MP0005310_abnormal_salivary_gland | 1.29392368 |
| 61 | MP0002006_tumorigenesis | 1.27842733 |
| 62 | MP0003303_peritoneal_inflammation | 1.27694455 |
| 63 | MP0005671_abnormal_response_to | 1.27572696 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.26361991 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.25039240 |
| 66 | MP0000749_muscle_degeneration | 1.23489463 |
| 67 | MP0002332_abnormal_exercise_endurance | 1.20773064 |
| 68 | MP0000858_altered_metastatic_potential | 1.20032862 |
| 69 | MP0003634_abnormal_glial_cell | 1.19015153 |
| 70 | MP0005365_abnormal_bile_salt | 1.15506951 |
| 71 | MP0002723_abnormal_immune_serum | 1.15417541 |
| 72 | MP0004858_abnormal_nervous_system | 1.13338908 |
| 73 | MP0002420_abnormal_adaptive_immunity | 1.11737022 |
| 74 | MP0003879_abnormal_hair_cell | 1.10756445 |
| 75 | MP0009046_muscle_twitch | 1.10441010 |
| 76 | MP0001819_abnormal_immune_cell | 1.10311734 |
| 77 | MP0005083_abnormal_biliary_tract | 1.09934290 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 1.08968554 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.08454092 |
| 80 | MP0001845_abnormal_inflammatory_respons | 1.06702089 |
| 81 | MP0008775_abnormal_heart_ventricle | 1.06032587 |
| 82 | MP0004043_abnormal_pH_regulation | 1.05960308 |
| 83 | MP0002090_abnormal_vision | 1.03945127 |
| 84 | MP0002277_abnormal_respiratory_mucosa | 1.01786730 |
| 85 | MP0000538_abnormal_urinary_bladder | 1.00899068 |
| 86 | MP0001919_abnormal_reproductive_system | 1.00208469 |
| 87 | MP0003787_abnormal_imprinting | 0.99993439 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.97923444 |
| 89 | MP0001790_abnormal_immune_system | 0.97131828 |
| 90 | MP0005387_immune_system_phenotype | 0.97131828 |
| 91 | MP0001756_abnormal_urination | 0.96488211 |
| 92 | MP0008469_abnormal_protein_level | 0.96266983 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.95959719 |
| 94 | MP0002139_abnormal_hepatobiliary_system | 0.95806861 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.94768572 |
| 96 | MP0009697_abnormal_copulation | 0.94710186 |
| 97 | MP0001984_abnormal_olfaction | 0.94606802 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.94462770 |
| 99 | MP0001958_emphysema | 0.93783940 |
| 100 | MP0000372_irregular_coat_pigmentation | 0.93604906 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.92730563 |
| 102 | MP0001765_abnormal_ion_homeostasis | 0.91978219 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.90750499 |
| 104 | MP0009278_abnormal_bone_marrow | 0.90597174 |
| 105 | MP0005171_absent_coat_pigmentation | 0.90574302 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.90166950 |
| 107 | MP0004130_abnormal_muscle_cell | 0.89926086 |
| 108 | MP0003075_altered_response_to | 0.89527282 |
| 109 | MP0003698_abnormal_male_reproductive | 0.88511718 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.87731329 |
| 111 | MP0004019_abnormal_vitamin_homeostasis | 0.87237106 |
| 112 | MP0001800_abnormal_humoral_immune | 0.87187679 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.86905919 |
| 114 | MP0000371_diluted_coat_color | 0.86069377 |
| 115 | MP0004264_abnormal_extraembryonic_tissu | 0.85829894 |
| 116 | MP0005535_abnormal_body_temperature | 0.84272946 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.84250422 |
| 118 | MP0003633_abnormal_nervous_system | 0.83810285 |
| 119 | MP0000920_abnormal_myelination | 0.83518815 |
| 120 | MP0003795_abnormal_bone_structure | 0.82984862 |
| 121 | MP0005451_abnormal_body_composition | 0.82343439 |
| 122 | MP0002064_seizures | 0.82261816 |
| 123 | MP0010234_abnormal_vibrissa_follicle | 0.81920391 |
| 124 | MP0008872_abnormal_physiological_respon | 0.81197502 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.80385296 |
| 126 | MP0003656_abnormal_erythrocyte_physiolo | 0.80274884 |
| 127 | MP0000685_abnormal_immune_system | 0.79995333 |
| 128 | MP0002909_abnormal_adrenal_gland | 0.79514217 |
| 129 | MP0005165_increased_susceptibility_to | 0.78926496 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.78809791 |
| 131 | MP0002405_respiratory_system_inflammati | 0.78547216 |
| 132 | MP0001188_hyperpigmentation | 0.78183113 |
| 133 | MP0002933_joint_inflammation | 0.77876316 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.77134985 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.77134985 |
| 136 | MP0001542_abnormal_bone_strength | 0.76143415 |
| 137 | MP0003786_premature_aging | 0.75844289 |
| 138 | MP0005266_abnormal_metabolism | 0.75567315 |
| 139 | MP0004036_abnormal_muscle_relaxation | 0.74755449 |
| 140 | MP0003279_aneurysm | 0.74160049 |
| 141 | MP0005367_renal/urinary_system_phenotyp | 0.74141793 |
| 142 | MP0000516_abnormal_urinary_system | 0.74141793 |
| 143 | MP0005166_decreased_susceptibility_to | 0.73699585 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.73076380 |
| 145 | MP0005220_abnormal_exocrine_pancreas | 0.72984776 |
| 146 | MP0004484_altered_response_of | 0.72835328 |
| 147 | MP0003448_altered_tumor_morphology | 0.72257556 |
| 148 | MP0001970_abnormal_pain_threshold | 0.70757970 |
| 149 | MP0001764_abnormal_homeostasis | 0.70234780 |
| 150 | MP0001905_abnormal_dopamine_level | 0.69590840 |
| 151 | MP0000358_abnormal_cell_content/ | 0.69033483 |
| 152 | MP0003566_abnormal_cell_adhesion | 0.68977070 |
| 153 | MP0000490_abnormal_crypts_of | 0.66843537 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.63359377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 7.33482222 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 6.55978730 |
| 3 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.22297439 |
| 4 | Dysostosis multiplex (HP:0000943) | 5.99554230 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.58519685 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.58519685 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 5.58519685 |
| 8 | Recurrent abscess formation (HP:0002722) | 5.06331352 |
| 9 | Mucopolysacchariduria (HP:0008155) | 4.74747179 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.74747179 |
| 11 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.55106322 |
| 12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.55106322 |
| 13 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.55106322 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.52087307 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.35238322 |
| 16 | Ketoacidosis (HP:0001993) | 4.17781835 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.70040275 |
| 18 | Axonal loss (HP:0003447) | 3.66634951 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 3.58562033 |
| 20 | Loss of speech (HP:0002371) | 3.41562405 |
| 21 | Ketosis (HP:0001946) | 3.31249899 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.20861797 |
| 23 | Disinhibition (HP:0000734) | 3.19761500 |
| 24 | Methylmalonic acidemia (HP:0002912) | 3.08387325 |
| 25 | Progressive neurologic deterioration (HP:0002344) | 3.02751700 |
| 26 | J-shaped sella turcica (HP:0002680) | 3.02522656 |
| 27 | Large for gestational age (HP:0001520) | 2.98948801 |
| 28 | Abolished electroretinogram (ERG) (HP:0000550) | 2.88350156 |
| 29 | Absent/shortened dynein arms (HP:0200106) | 2.88185912 |
| 30 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.88185912 |
| 31 | Tongue fasciculations (HP:0001308) | 2.84393015 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.84040536 |
| 33 | Hypoalbuminemia (HP:0003073) | 2.81040708 |
| 34 | Abnormal albumin level (HP:0012116) | 2.81040708 |
| 35 | Methylmalonic aciduria (HP:0012120) | 2.76994551 |
| 36 | Hyperglycemia (HP:0003074) | 2.76409984 |
| 37 | Renal cortical cysts (HP:0000803) | 2.73376105 |
| 38 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.73168773 |
| 39 | Myositis (HP:0100614) | 2.72351080 |
| 40 | Asymmetric septal hypertrophy (HP:0001670) | 2.71756750 |
| 41 | Hypoglycemic coma (HP:0001325) | 2.69391988 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.67182417 |
| 43 | Pancreatic cysts (HP:0001737) | 2.62477858 |
| 44 | Joint stiffness (HP:0001387) | 2.60573178 |
| 45 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.58811779 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.58811779 |
| 47 | Spinal muscular atrophy (HP:0007269) | 2.55453086 |
| 48 | Stomatitis (HP:0010280) | 2.54650544 |
| 49 | Cervical subluxation (HP:0003308) | 2.53956998 |
| 50 | Chronic hepatic failure (HP:0100626) | 2.50711590 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.45587007 |
| 52 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.44969338 |
| 53 | Upper motor neuron abnormality (HP:0002127) | 2.43104199 |
| 54 | Abnormality of vitamin B metabolism (HP:0004340) | 2.40244573 |
| 55 | Muscle fibrillation (HP:0010546) | 2.39132002 |
| 56 | Attenuation of retinal blood vessels (HP:0007843) | 2.37723581 |
| 57 | Retinal atrophy (HP:0001105) | 2.37432644 |
| 58 | Neurodegeneration (HP:0002180) | 2.36302631 |
| 59 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.34275398 |
| 60 | Thyroiditis (HP:0100646) | 2.34210087 |
| 61 | Agnosia (HP:0010524) | 2.34083825 |
| 62 | Type II lissencephaly (HP:0007260) | 2.31046164 |
| 63 | Abnormality of dental color (HP:0011073) | 2.30982013 |
| 64 | Clumsiness (HP:0002312) | 2.29850502 |
| 65 | Abnormality of the renal cortex (HP:0011035) | 2.29491589 |
| 66 | Generalized aminoaciduria (HP:0002909) | 2.29172087 |
| 67 | Personality changes (HP:0000751) | 2.28907326 |
| 68 | IgG deficiency (HP:0004315) | 2.28241193 |
| 69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27560145 |
| 70 | Molar tooth sign on MRI (HP:0002419) | 2.26468278 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.26468278 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.26359544 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25372270 |
| 74 | Dicarboxylic aciduria (HP:0003215) | 2.25372270 |
| 75 | Mutism (HP:0002300) | 2.22352243 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.21541574 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21541574 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21541574 |
| 79 | Abnormal protein glycosylation (HP:0012346) | 2.21541574 |
| 80 | Supranuclear gaze palsy (HP:0000605) | 2.17809932 |
| 81 | Glomerulonephritis (HP:0000099) | 2.16718793 |
| 82 | Chronic diarrhea (HP:0002028) | 2.16189357 |
| 83 | Late onset (HP:0003584) | 2.14552897 |
| 84 | Hypoplasia of the odontoid process (HP:0003311) | 2.13385721 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12020315 |
| 86 | Pathologic fracture (HP:0002756) | 2.11300060 |
| 87 | Hepatocellular necrosis (HP:0001404) | 2.11053784 |
| 88 | Pancreatic fibrosis (HP:0100732) | 2.10153333 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.09136212 |
| 90 | Albinism (HP:0001022) | 2.08716810 |
| 91 | Hypoglycemic seizures (HP:0002173) | 2.08196272 |
| 92 | Pendular nystagmus (HP:0012043) | 2.06672965 |
| 93 | Type I transferrin isoform profile (HP:0003642) | 2.05691743 |
| 94 | Gingivitis (HP:0000230) | 2.04528721 |
| 95 | Disproportionate short-trunk short stature (HP:0003521) | 2.03427787 |
| 96 | Abnormal pancreas size (HP:0012094) | 2.00014829 |
| 97 | Petechiae (HP:0000967) | 1.99442582 |
| 98 | Orchitis (HP:0100796) | 1.99437946 |
| 99 | Hypokinesia (HP:0002375) | 1.98988489 |
| 100 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.98389538 |
| 101 | Tachypnea (HP:0002789) | 1.98370491 |
| 102 | Hypoproteinemia (HP:0003075) | 1.96164586 |
| 103 | Acute hepatic failure (HP:0006554) | 1.95881075 |
| 104 | Hypomagnesemia (HP:0002917) | 1.95767394 |
| 105 | Beaking of vertebral bodies (HP:0004568) | 1.95500277 |
| 106 | Ovoid vertebral bodies (HP:0003300) | 1.95002218 |
| 107 | Increased CSF protein (HP:0002922) | 1.94559803 |
| 108 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.94317325 |
| 109 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.94317325 |
| 110 | Abnormal drinking behavior (HP:0030082) | 1.93541228 |
| 111 | Polydipsia (HP:0001959) | 1.93541228 |
| 112 | Hypothermia (HP:0002045) | 1.92840976 |
| 113 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92346659 |
| 114 | Obstructive lung disease (HP:0006536) | 1.92346659 |
| 115 | Facial diplegia (HP:0001349) | 1.92071200 |
| 116 | Neuroendocrine neoplasm (HP:0100634) | 1.91720428 |
| 117 | Myoclonus (HP:0001336) | 1.91394046 |
| 118 | Inappropriate behavior (HP:0000719) | 1.90352463 |
| 119 | Polyphagia (HP:0002591) | 1.87409974 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 1.86807932 |
| 121 | Increased CSF lactate (HP:0002490) | 1.86040235 |
| 122 | Hematochezia (HP:0002573) | 1.85701707 |
| 123 | Diminished motivation (HP:0000745) | 1.85523858 |
| 124 | Abnormality of methionine metabolism (HP:0010901) | 1.83550798 |
| 125 | Inability to walk (HP:0002540) | 1.81377725 |
| 126 | Basal ganglia calcification (HP:0002135) | 1.81041896 |
| 127 | Barrel-shaped chest (HP:0001552) | 1.79864085 |
| 128 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.79809234 |
| 129 | Agitation (HP:0000713) | 1.79390995 |
| 130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78977239 |
| 131 | Abnormality of alanine metabolism (HP:0010916) | 1.78977239 |
| 132 | Hyperalaninemia (HP:0003348) | 1.78977239 |
| 133 | Retrobulbar optic neuritis (HP:0100654) | 1.77658136 |
| 134 | Optic neuritis (HP:0100653) | 1.77658136 |
| 135 | Recurrent skin infections (HP:0001581) | 1.77483659 |
| 136 | Glycosuria (HP:0003076) | 1.75557720 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.75557720 |
| 138 | Neurofibrillary tangles (HP:0002185) | 1.75472857 |
| 139 | Abnormality of the odontoid process (HP:0003310) | 1.74331005 |
| 140 | Congenital stationary night blindness (HP:0007642) | 1.71773534 |
| 141 | Mitochondrial inheritance (HP:0001427) | 1.71658135 |
| 142 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71290064 |
| 143 | Abnormality of eosinophils (HP:0001879) | 1.71245867 |
| 144 | Apathy (HP:0000741) | 1.70090908 |
| 145 | Akinesia (HP:0002304) | 1.69918954 |
| 146 | Poor head control (HP:0002421) | 1.69621069 |
| 147 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69615964 |
| 148 | Renal Fanconi syndrome (HP:0001994) | 1.69228957 |
| 149 | Type I diabetes mellitus (HP:0100651) | 1.68273862 |
| 150 | Ulnar deviation of the wrist (HP:0003049) | 1.68218784 |
| 151 | Episodic fever (HP:0001954) | 1.67986275 |
| 152 | Thoracic kyphosis (HP:0002942) | 1.67604576 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.67311256 |
| 154 | Hyperlipoproteinemia (HP:0010980) | 1.67300691 |
| 155 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.66816117 |
| 156 | Vertebral compression fractures (HP:0002953) | 1.66043884 |
| 157 | Progressive visual loss (HP:0000529) | 1.65688949 |
| 158 | Diplopia (HP:0000651) | 1.64862113 |
| 159 | Abnormality of binocular vision (HP:0011514) | 1.64862113 |
| 160 | Dementia (HP:0000726) | 1.64539562 |
| 161 | Nasal polyposis (HP:0100582) | 1.61707351 |
| 162 | Hepatic necrosis (HP:0002605) | 1.60116364 |
| 163 | Acute necrotizing encephalopathy (HP:0006965) | 1.59749114 |
| 164 | Dysautonomia (HP:0002459) | 1.55358563 |
| 165 | Spondylolisthesis (HP:0003302) | 1.53891032 |
| 166 | Tetraparesis (HP:0002273) | 1.50852727 |
| 167 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.49852205 |
| 168 | Deformed sella turcica (HP:0002681) | 1.47262230 |
| 169 | Tetany (HP:0001281) | 1.46002235 |
| 170 | Bone cyst (HP:0012062) | 1.45234342 |
| 171 | Rhinitis (HP:0012384) | 1.45022681 |
| 172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.44986437 |
| 173 | Impaired platelet aggregation (HP:0003540) | 1.44986340 |
| 174 | Abnormal platelet function (HP:0011869) | 1.44986340 |
| 175 | Pulmonary infiltrates (HP:0002113) | 1.44803904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.44279426 |
| 2 | TXK | 4.18962645 |
| 3 | IRAK3 | 3.94184848 |
| 4 | ZAK | 3.41855110 |
| 5 | KIT | 3.27180242 |
| 6 | BLK | 3.26448925 |
| 7 | IRAK4 | 2.91769419 |
| 8 | PIM2 | 2.84541065 |
| 9 | STK16 | 2.61406423 |
| 10 | RIPK4 | 2.60559448 |
| 11 | MST4 | 2.57606221 |
| 12 | INSRR | 2.46024268 |
| 13 | CAMKK2 | 2.41964478 |
| 14 | CASK | 2.30769427 |
| 15 | ACVR1B | 2.21247772 |
| 16 | PDK3 | 2.13013077 |
| 17 | PDK4 | 2.13013077 |
| 18 | PHKG1 | 2.11131538 |
| 19 | PHKG2 | 2.11131538 |
| 20 | TGFBR2 | 2.07720081 |
| 21 | TBK1 | 2.04805912 |
| 22 | NME2 | 1.97259579 |
| 23 | FER | 1.96975198 |
| 24 | PIK3CG | 1.87182132 |
| 25 | MAP4K2 | 1.82684632 |
| 26 | ARAF | 1.81023990 |
| 27 | TLK1 | 1.79013182 |
| 28 | TAOK3 | 1.74358067 |
| 29 | EPHA3 | 1.73670942 |
| 30 | GRK1 | 1.73591235 |
| 31 | TIE1 | 1.70359491 |
| 32 | ERN1 | 1.66805412 |
| 33 | CSF1R | 1.62043868 |
| 34 | OBSCN | 1.58823108 |
| 35 | PDK2 | 1.57105722 |
| 36 | TYK2 | 1.54242512 |
| 37 | GRK7 | 1.50578892 |
| 38 | BMPR1B | 1.42645707 |
| 39 | FLT3 | 1.37059267 |
| 40 | PINK1 | 1.36333306 |
| 41 | SCYL2 | 1.35983116 |
| 42 | TEC | 1.32978766 |
| 43 | MAPK15 | 1.32369725 |
| 44 | FES | 1.30284175 |
| 45 | IRAK1 | 1.27375328 |
| 46 | MAP3K3 | 1.26585545 |
| 47 | ERBB3 | 1.23251947 |
| 48 | RPS6KA2 | 1.22780363 |
| 49 | ADRBK2 | 1.22645287 |
| 50 | PRKD3 | 1.21699445 |
| 51 | MAP3K14 | 1.21634423 |
| 52 | GRK6 | 1.17016139 |
| 53 | PAK3 | 1.11745243 |
| 54 | MUSK | 1.11687091 |
| 55 | MYLK | 1.11673142 |
| 56 | TNIK | 1.06333625 |
| 57 | MATK | 1.03595325 |
| 58 | ZAP70 | 1.03355570 |
| 59 | SYK | 1.02808729 |
| 60 | CCNB1 | 0.99832857 |
| 61 | TRPM7 | 0.99123224 |
| 62 | AKT3 | 0.95654993 |
| 63 | PTK2B | 0.93536427 |
| 64 | TESK1 | 0.93190773 |
| 65 | NUAK1 | 0.92703669 |
| 66 | IRAK2 | 0.92019481 |
| 67 | CHUK | 0.90898207 |
| 68 | LYN | 0.90879922 |
| 69 | PRKAA2 | 0.89700203 |
| 70 | RPS6KA6 | 0.88794021 |
| 71 | MAPKAPK3 | 0.88188868 |
| 72 | BRAF | 0.87203549 |
| 73 | CSNK1G3 | 0.85662337 |
| 74 | MAP3K11 | 0.84461988 |
| 75 | ITK | 0.83643755 |
| 76 | MAP3K12 | 0.83030337 |
| 77 | TESK2 | 0.81576467 |
| 78 | EIF2AK3 | 0.81109530 |
| 79 | DAPK1 | 0.80508536 |
| 80 | BTK | 0.80437575 |
| 81 | RPS6KC1 | 0.80432194 |
| 82 | RPS6KL1 | 0.80432194 |
| 83 | FGR | 0.78855659 |
| 84 | STK24 | 0.77935875 |
| 85 | NTRK1 | 0.77317411 |
| 86 | HIPK2 | 0.77289412 |
| 87 | MAPKAPK5 | 0.77250545 |
| 88 | IKBKB | 0.76778692 |
| 89 | PRKCD | 0.75498801 |
| 90 | PASK | 0.74628430 |
| 91 | YES1 | 0.74260173 |
| 92 | PRKCE | 0.73577440 |
| 93 | BMPR2 | 0.73549470 |
| 94 | MAP4K1 | 0.73056689 |
| 95 | PRKCQ | 0.72854147 |
| 96 | MAP3K4 | 0.72780081 |
| 97 | MAP2K7 | 0.72715384 |
| 98 | WNK4 | 0.72401641 |
| 99 | MAPK11 | 0.70282152 |
| 100 | JAK1 | 0.70076126 |
| 101 | CSNK1G1 | 0.68909537 |
| 102 | RPS6KA5 | 0.65984571 |
| 103 | PAK4 | 0.65208184 |
| 104 | BRSK2 | 0.65167571 |
| 105 | CSNK1G2 | 0.61187145 |
| 106 | JAK3 | 0.60160926 |
| 107 | PRKCG | 0.59840912 |
| 108 | LIMK1 | 0.58594170 |
| 109 | MAP3K5 | 0.58310295 |
| 110 | EPHB1 | 0.58135507 |
| 111 | BCKDK | 0.58037198 |
| 112 | FGFR2 | 0.57807966 |
| 113 | TGFBR1 | 0.57011196 |
| 114 | PRKAA1 | 0.56549466 |
| 115 | IGF1R | 0.55678884 |
| 116 | MAP2K6 | 0.53497131 |
| 117 | KDR | 0.52510580 |
| 118 | OXSR1 | 0.51910242 |
| 119 | LCK | 0.51585527 |
| 120 | CLK1 | 0.51354845 |
| 121 | CAMKK1 | 0.51033212 |
| 122 | RPS6KA4 | 0.50938453 |
| 123 | MARK3 | 0.50894754 |
| 124 | TSSK6 | 0.50799301 |
| 125 | PLK2 | 0.49333735 |
| 126 | STK39 | 0.49332170 |
| 127 | SGK2 | 0.48524991 |
| 128 | CSNK1A1L | 0.48163023 |
| 129 | IKBKE | 0.48113187 |
| 130 | MAP2K3 | 0.46795382 |
| 131 | TAOK1 | 0.46644332 |
| 132 | ADRBK1 | 0.46150922 |
| 133 | NTRK3 | 0.44765544 |
| 134 | CDK8 | 0.44191541 |
| 135 | FGFR3 | 0.43091101 |
| 136 | MAP3K1 | 0.41153997 |
| 137 | STK38L | 0.40741943 |
| 138 | NLK | 0.40241361 |
| 139 | STK38 | 0.39363186 |
| 140 | PDPK1 | 0.38686276 |
| 141 | MAPK13 | 0.36984117 |
| 142 | TNK2 | 0.36824375 |
| 143 | VRK1 | 0.36076339 |
| 144 | ABL1 | 0.35862308 |
| 145 | CSNK1A1 | 0.35186876 |
| 146 | GRK5 | 0.35178875 |
| 147 | MAP3K2 | 0.34456527 |
| 148 | PRKCZ | 0.34434999 |
| 149 | ABL2 | 0.33101592 |
| 150 | SGK223 | 0.33031269 |
| 151 | SGK494 | 0.33031269 |
| 152 | HCK | 0.32069813 |
| 153 | DAPK3 | 0.29894997 |
| 154 | WNK3 | 0.28964907 |
| 155 | DAPK2 | 0.26207583 |
| 156 | PIM1 | 0.25581088 |
| 157 | MAPK4 | 0.23419849 |
| 158 | CSK | 0.23019378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.91120098 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.59093735 |
| 3 | Lysosome_Homo sapiens_hsa04142 | 4.25652812 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.52314052 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.13158387 |
| 6 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.11811203 |
| 7 | Phagosome_Homo sapiens_hsa04145 | 2.51002021 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.44279386 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.14064327 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.05222828 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00500744 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.90908661 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89574461 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.86161913 |
| 15 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.82649873 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.82057165 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77881546 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75052632 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.73852894 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66842520 |
| 21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.65098252 |
| 22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64998038 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64440575 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64031694 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.62932149 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.51933608 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49362349 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46677860 |
| 29 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44596903 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.42194511 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39344910 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37208467 |
| 33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31228890 |
| 34 | Peroxisome_Homo sapiens_hsa04146 | 1.30662207 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.30547632 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.28832741 |
| 37 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.26455998 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.22811024 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20831036 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16174305 |
| 41 | Leishmaniasis_Homo sapiens_hsa05140 | 1.13635772 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13402914 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13379227 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12795273 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12122510 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10234901 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06372422 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04499856 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04280426 |
| 50 | Phototransduction_Homo sapiens_hsa04744 | 1.03722294 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.01915096 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01204969 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01136453 |
| 54 | RNA polymerase_Homo sapiens_hsa03020 | 0.98525847 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97694124 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95434659 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92588645 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87888031 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.86511289 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83824932 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82803836 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.81350187 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.77427968 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77167807 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.75236231 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74944550 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74868897 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71621909 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71270951 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69441146 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68988156 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65938765 |
| 73 | Proteasome_Homo sapiens_hsa03050 | 0.65433015 |
| 74 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65393355 |
| 75 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63351323 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.63195388 |
| 77 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62965715 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61660447 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61176826 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.60495418 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.59412104 |
| 82 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59327746 |
| 83 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59021521 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58712577 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58442677 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58185896 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.57594423 |
| 88 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57231773 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57153394 |
| 90 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56328729 |
| 91 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.56178648 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55475255 |
| 93 | Influenza A_Homo sapiens_hsa05164 | 0.55204301 |
| 94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54095213 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53051129 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52118936 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50333699 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50277445 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50066700 |
| 100 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49995545 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48676932 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47862465 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47555319 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.47516927 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47097356 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.46801442 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44049794 |
| 108 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43935089 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43843420 |
| 110 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41921802 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40509932 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39490498 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39462145 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.38928205 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.36851073 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35943988 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.35259942 |
| 118 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35045484 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34016104 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.33467295 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32081891 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32017973 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31587394 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.31053196 |
| 125 | Purine metabolism_Homo sapiens_hsa00230 | 0.31007288 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30698494 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30407152 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.29460586 |
| 129 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28884569 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27915494 |
| 131 | Cocaine addiction_Homo sapiens_hsa05030 | 0.27055626 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25835408 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.25505126 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24347496 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.23786586 |
| 136 | Allograft rejection_Homo sapiens_hsa05330 | 0.23515828 |
| 137 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.21727915 |
| 138 | Renin secretion_Homo sapiens_hsa04924 | 0.21635146 |
| 139 | ABC transporters_Homo sapiens_hsa02010 | 0.21450420 |
| 140 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21194036 |
| 141 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21082673 |
| 142 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20858309 |
| 143 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.20246656 |
| 144 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.20168946 |
| 145 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.18670276 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18519196 |

